BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results

  Consolidated net revenues for the fourth quarter of 2017 were $52.0 million, a 47% increase from the fourth quarter of 2016.

  February 8, 2018

   · 

  17 min read
• Business

  Newron Pharmaceuticals S.p.A. Announces Change in the Board of Directors

  Newron today announced that Bo Jesper Hansen has informed the Board of Directors of his intention to step down as a Non-Executive Director, effective from this year’s Annual Shareholders Assembly taking place on March 27, 2018.

  February 8, 2018

   · 

  5 min read
• Biotech Bay

  California Life Sciences Association Recognizes Senator Patricia Bates and Assemblymembers Heath Flora, Rob Bonta as Champions of Biomedical Innovation

  California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, honored three California state legislators as Life Sciences Champions during its Back to Session Reception in Sacramento that took place on February 7.

  February 8, 2018

   · 

  3 min read
• 

  Deals

  Bay Area Medical Device Firm Acquires Corpus Medical

  Confluent Medical Technologies completed the acquisition of Corpus Medical. Confluent Medical is a contract manufacturer with full scale capabilities to provide high-quality, low cost finished class III medical devices.

  February 8, 2018

   · 

  4 min read
• Biotech Bay

  Adverum Biotechnologies Announces Proposed Public Offering of Common Stock

  The offering is subject to market and other conditions, and there can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

  February 8, 2018

   · 

  3 min read
• Business

  Hologic Announces Financial Results for First Quarter of Fiscal 2018

  Hologic announced today the Company’s financial results for the fiscal first quarter ended December 30, 2017.

  February 8, 2018

   · 

  71 min read
• National Comprehensive Cancer Network adds Jazz Pharma’s Vyxeos Liposome for Injection to Clinical Practice Guidelines in Oncology

  Vyxeos is the first FDA-approved treatment specifically for adults with newly-diagnosed Therapy-Related AML or AML with AML-MRC.

  February 8, 2018

   · 

  8 min read
• FDA

  QIAGEN’s QuantiFERON-TB Gold Plus Gains Approval in Japan

  QIAGEN N.V. today announced that Japan’s Ministry of Health Labor and Welfare has approved QuantiFERON-TB Gold Plus (QFT-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection.

  February 8, 2018

   · 

  1 min read
• Business

  Innoviva Reports Record Fourth Quarter and Full Year 2017 Financial Results

  Income from operations for the fourth quarter of 2017 was $66.4 million, compared with $37.7 million for the same period in 2016.

  February 8, 2018

   · 

  16 min read
• Business

  Nevro to Report Operating Results for the Fourth Quarter and Full Year 2017

  Following the call, a replay will be available on the Investor Events and Presentations webpage of the Company’s website.

  February 8, 2018

   · 

  1 min read